Literature DB >> 33284081

Speech intelligibility test methodology applied to powered air-purifying respirators used in healthcare.

Susan Xu1, Jeremy Simons1, Patrick Yorio1, Dana Rottach1, Ziqing Zhuang1, Lewis Radonovich1.   

Abstract

Powered air-purifying respirators (PAPRs) are worn to protect workers from hazardous respiratory exposures in a wide range of workplaces, including healthcare. However, PAPRs may diminish the ability of wearers to correctly hear words spoken by others, potentially interfering with safe performance of healthcare duties. Accordingly, the impact of PAPRs during healthcare use on speech intelligibility (SI) and consequently on user safety, usability, and patient care is not well studied. The objectives of this study were to (1) determine a listener's ability to comprehend single-syllable words spoken by a PAPR wearer; (2) determine a PAPR wearer's ability to intelligibly hear and identify single-syllable words spoken by a PAPR wearer; (3) to assess the variability between speakers, listeners, and PAPR models; (4) to investigate the effects of PAPR design features on SI; and (5) inform a SI requirement for certifying future PAPRs for use in healthcare. This study utilized a Modified Rhyme Test to assess SI for PAPRs. The current National Institute for Occupational Safety and Health (NIOSH) methods for assessing SI are limited to the recently introduced PAPR100 respirator class and the class of respirators claiming chemical, biological, radiological, and nuclear (CBRN) protections. Four NIOSH-approved PAPRs were evaluated using four human subjects. Four experimental conditions were examined:(1) Speaker and Listener with no PAPR; (2) Speaker and Listener both wearing PAPRs; (3) Speaker with a PAPR, Listener without a PAPR; and (4) Speaker without a PAPR, Listener with a PAPR resulted in a total of 144 experiments. Statistical analysis showed that the SI performance ratings were not significantly different among the PAPR models, but experimental conditions had significant impact on SI. The pattern of SI across the conditions of the experiment also showed a significant difference depending on PAPR model. The SI performance rating for all PAPRs could meet the current NIOSH CBRN certification requirement for speech intelligibility.

Entities:  

Keywords:  Communication; NIOSH; PAPR; health care worker (HCW); safety

Year:  2020        PMID: 33284081      PMCID: PMC8028038          DOI: 10.1080/15459624.2020.1844891

Source DB:  PubMed          Journal:  J Occup Environ Hyg        ISSN: 1545-9624            Impact factor:   2.155


  7 in total

1.  Chemical protective clothing; a study into the ability of staff to perform lifesaving procedures.

Authors:  M J Coates; A S Jundi; M R James
Journal:  J Accid Emerg Med       Date:  2000-03

2.  Respiratory protection--OSHA. Final rule; request for comment on paperwork requirements.

Authors: 
Journal:  Fed Regist       Date:  1998-01-08

3.  ARTICULATION-TESTING METHODS: CONSONANTAL DIFFERENTIATION WITH A CLOSED-RESPONSE SET.

Authors:  A S HOUSE; C E WILLIAMS; M H HEKER; K D KRYTER
Journal:  J Acoust Soc Am       Date:  1965-01       Impact factor: 1.840

4.  Diminished speech intelligibility associated with certain types of respirators worn by healthcare workers.

Authors:  Lewis J Radonovich; Robert Yanke; Jing Cheng; Bradley Bender
Journal:  J Occup Environ Hyg       Date:  2010-01       Impact factor: 2.155

5.  Respirator performance ratings for speech intelligibility.

Authors:  K M Coyne; A T Johnson; G H Yeni-Komshian; C R Dooly
Journal:  Am Ind Hyg Assoc J       Date:  1998-04

6.  Prevalence of Respiratory Protective Devices in U.S. Health Care Facilities: Implications for Emergency Preparedness.

Authors:  Kerri Wizner; Lindsay Stradtman; Debra Novak; Ronald Shaffer
Journal:  Workplace Health Saf       Date:  2016-08       Impact factor: 1.413

Review 7.  Evaluation of the rationale for concurrent use of N95 filtering facepiece respirators with loose-fitting powered air-purifying respirators during aerosol-generating medical procedures.

Authors:  Raymond J Roberge
Journal:  Am J Infect Control       Date:  2008-03       Impact factor: 2.918

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.